AKCESO RECENT NEWS
20th April 2016: Akceso presenting at Duale Hochschule Baden-Württemberg on April 20th
Dr. András Incze, CEO of Akceso Advisors, will be speaking on the topic of 'An Emerging Pricing Ethic in Pharma - after Sovaldi, Valeant and Turing Pharma' at the DHBW in Lörrach, as part of their series 'Conversations on Healthcare Themes'.
A preview article is available here in German.
Contact Kinga Brady for more information
25th February 2016: Inaugural Akceso Network Event for Payors & Executives.
Akceso hosted a discussion meeting in Zurich for senior payors and selected pharma Pricing & Market Access executives. Our keynote speaker is Dr. Tomás Tesar, member of the Working Group for Pharmacoeconomics, Clinical Outcomes and Health Technology Assessment of the Slovak MoH, representative of Slovakia in EUnetHTA. Mr Tesar will speak about “Public funding sustainability trends – in light of new costly drugs
January 2016: Akceso presenting at Saïd Business School
Chris Shilling, Advisor at Akceso Advisors AG, delivered a training seminar on Pricing and Reimbursement of Medical Technology at Oxford University's Saïd Business School in support of the Oxford Biotech BioStars programme
(for daily news please go to Akceso's Twitter Page)
April 30th - Report Hightlights Impact of Pricing Policy on Innovation
A new report by independent think tank the Information Technology & Innovation Foundation has highlighted the impact of national pricing policies on pharmaceutical innovation, exploring key indicators across over 50 countries.
March 24th - New EU Report on Reference Pricing
A new EU report provides an in-depth review of pharmaceutcial pricing practices in Europe, with a particular focus on International Reference Pricing.
February 1st - Scotland's SMC to be reviewed
The Scottish Health Secretary has announced a full review of the SMC's process.